KemPharm registers $57.5 million of stock for initial public offering

Cowen, RBC Capital Canaccord Genuity and Oppenheimer assist with sale

By Devika Patel

Knoxville, Tenn., March 11 – KemPharm, Inc. will conduct an initial public offering of its common stock with a 30-day greenshoe, according to a Form S-1 filed Wednesday with the Securities and Exchange Commission. The company has registered up to $57.5 million of stock.

Cowen and Co. and RBC Capital Markets are the bookrunning managers. Canaccord Genuity and Oppenheimer & Co. are the co-managers.

Proceeds will be used for clinical trials, research and development, working capital and other general corporate purposes.

The clinical-stage specialty pharmaceutical company is based in Coralville, Iowa. The company intends to list its common stock on the Nasdaq under the symbol “KMPH.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.